BIONDI ANDREA

Position:
Direttore di Scuola di Specializzazione (Universita' di Milano Bicocca)
Role
Former Full Professor  
Academic disciplines
Paediatrics (MEDS-20/A)
Scientific-Disciplinary Group:
PAEDIATRICS AND CHILD NEUROPSYCHIATRY (06/MEDS-20)
Room:
  • U06, Floor: 4, Room: 4010B

Publications

  • Civettini, I., Zappaterra, A., Corti, P., Messina, A., Aroldi, A., Biondi, A., et al. (2025). Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype. MED, 6(4) [10.1016/j.medj.2024.11.007]. Detail

  • Peccatori, N., Coppola, M., Colombini, A., Silvestri, D., Bertorello, N., Kiren, V., et al. (2025). Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases. EJC PAEDIATRIC ONCOLOGY, 5(June 2025) [10.1016/j.ejcped.2024.100202]. Detail

  • Battistelli, E., Calabria, O., Giani, M., Moretto, A., Cattaneo, F., Alberio, G., et al. (2025). Perioperative Management and Outcomes of Pediatric Craniosynostosis Patients Undergoing Cranioplasty: A Retrospective Analysis. THE JOURNAL OF CRANIOFACIAL SURGERY, 36(1 (January/February 2025)), 215-218 [10.1097/SCS.0000000000010723]. Detail

  • Snyder, T., Gittelman, R., Klinger, M., May, D., Osborne, E., Taniguchi, R., et al. (2025). Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels. FRONTIERS IN IMMUNOLOGY, 15 [10.3389/fimmu.2024.1488860]. Detail

  • Di Majo, B., Peccatori, N., Inzoli, A., Degrate, L., Jaconi, M., Ratti, M., et al. (2025). Case Report: Post-splenectomy bulky pelvic splenosis in an adolescent with hereditary spherocytosis. FRONTIERS IN PEDIATRICS, 13 [10.3389/fped.2025.1581533]. Detail

Research projects

Innovative CAR Therapy Platforms (INCAR) - V annualità
Year: 2023
Grantors: FONDAZIONE AIRC
Adoptive Chimeric Antigen Receptor cell therapy for the treatment of patients with Acute Myeloid Leukemia: Development of preclinical models to assess efficacy and safety
Year: 2021
Call: Decreto Direttoriale n.1628 del 16-10-2020 - Bando PRIN 2020
Grantors: M.I.U.R. - MINISTERO DELL'ISTRUZIONE, DELL'UNIVERSITA' E DELLA RICERCA
Innovative CAR Therapy Platforms INCAR - IV annualità
Year: 2021
Call: 2017-034 - Accelerator Award
Grantors: FUNDACION CIENTIFICA DE LA ASOCIACION ESPAGNOLA CONTRAL EL CANCER (AECC), CANCER RESEARCH UK, FONDAZIONE AIRC
Innovative CAR Therapy Platforms - INCAR III annualità
Year: 2020
Call: 2017-034 - Accelerator Award
Grantors: FUNDACION CIENTIFICA DE LA ASOCIACION ESPAGNOLA CONTRAL EL CANCER (AECC), CANCER RESEARCH UK, FONDAZIONE AIRC
Innovative CAR Therapy Platforms - INCAR II annualità
Year: 2019
Call: 2017-034 - Accelerator Award
Grantors: FUNDACION CIENTIFICA DE LA ASOCIACION ESPAGNOLA CONTRAL EL CANCER (AECC), FONDAZIONE AIRC, CANCER RESEARCH UK

Awards

Scientific fellowships

  • Fellow - International BFM Study Group, 2016
  • Fellow - European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), 2012
  • Fellow - Associazione Italiana di Ematologia ed Oncologia Pediatrica A.I.E.O.P., 2012
  • Fellow - The European Society for Paediatric Oncology (SIOPE), 2004

Management or corporate responsibility

  • Direttore Scientifico - Fondazione M.Tettamanti M.De Marchi, 2006
  • Direttore Scientifico - Fondazione Monza e Brianza per il Bambino e la sua Mamma - MBBM, 2010

Congresses/Conferences

  • Program chair - Annual Meeting International BFM Study Group(Repubblica Ceca), 2019
  • Program chair - European Hematology Association Paediatric Course, 2017
  • Program chair - Annual Meeting International BFM Study Group, 2017